Skip to main content
. 2017 Jan 22;2017:9161040. doi: 10.1155/2017/9161040

Table 3.

Trials with dexmedetomidine, tiletamine-zolazepam, and butorphanol (DTZB). Dexmedetomidine and tiletamine-zolazepam were administered IP and butorphanol was administered at 3 mg/kg SC. Data is reported in marginal means and standard error.

Anesthetic duration (minutes) Recovery time (minutes) Anesthesia achieved (%) Heart rate (bpm) Respiratory rate (bpm)
Dexmedetomidine 0.2 mg/kg
 Tiletamine-zolazepam
  10 mg/kg 28 (±21) 105 (±16) 50% (3/6) 188 (±12) 132 (±4)
  20 mg/kg 73 (±16) 168 (±16) 100% (6/6) 191 (±12) 137 (±4)
  40 mg/kg 143 (±16) 217 (±16) 100% (6/6) 198 (±12) 137 (±4)

Dexmedetomidine 0.4 mg/kg
 Tiletamine-zolazepam
  10 mg/kg 90 (±18) 161 (±16) 33% (2/6) 199 (±12) 129 (±4)
  20 mg/kg 110 (±16) 224 (±16) 100% (6/6) 202 (±12) 134 (±4)
  40 mg/kg 163 (±16) 273 (±16) 100% (6/6) 209 (±12) 134 (±4)

Dexmedetomidine 0.6 mg/kg
 Tiletamine-zolazepam
  10 mg/kg 80 (±16) 213 (±16) 100% (6/6) 195 (±12) 131 (±4)
  20 mg/kg 195 (17) 276 (±17) 100% (6/6) 198 (±12) 136 (±4)
  40 mg/kg 216 (±16) 325 (±16) 100% (6/6) 205 (±12) 136 (±4)